Lamotrigine in the maintenance treatment of bipolar disorder

Lamotrigine, an anticonvulsant drug, is licensed in the United States for the maintenance treatment of bipolar I disorder and in the UK to prevent depressive episodes in bipolar disorder. Hashimoto and colleagues (2021) performed a Cochrane Intervention Review to explore whether lamotrigine is effective and safe compared to the most established maintenance treatment, lithium, and placebo.

Michael Ostacher critically appraises and summarises a recent Cochrane systematic review, which presents the latest best evidence on the efficacy of lamotrigine in the maintenance treatment of bipolar disorder.

[read the full story...]

What do dementia stakeholders think about Cognitive Stimulation Therapy?

tiago-muraro-pwMds57bapI-unsplash

A group of students from the UCL MSc in Mental Health Studies summarise a review on dementia stakeholders’ perceptions of Cognitive Stimulation Therapy.

[read the full story...]

What do people with bipolar really pay attention to when they are monitoring their mood?

celpax-ZoGOw9WYMtQ-unsplash

Charlotte Walker reviews a recent qualitative study on monitoring mood in bipolar disorder, which suggests that people with lived experience should customise monitoring questions to create a more responsive, personalised approach.

[read the full story...]

Mood management can improve smoking cessation in patients with past and current depression

shutterstock_144960853

There is a high rate of co-morbidity between depression and smoking; rates of smoking are approximately double in those with depression compared with the general population. In addition, smokers with depression tend to have higher rates of nicotine dependence, suffer greater negative affect during abstinence/withdrawal, are more likely to fail in quit attempts, and are [read the full story…]